Activation of the Hippocampal LXRβ Improves Sleep-Deprived Cognitive Impairment by Inhibiting Neuroinflammation

Mol Neurobiol. 2021 Oct;58(10):5272-5288. doi: 10.1007/s12035-021-02446-2. Epub 2021 Jul 19.

Abstract

Sleep deprivation (SD) leads to cognitive impairment due to neuroinflammation associated with impaired hippocampal neuronal plasticity and memory processes. Liver X receptors (LXRs), including LXRα and LXRβ isoforms, are crucial for synaptic plasticity and neuroinflammation. However, the potential roles of LXRs in the pathogenesis of cognitive impairment induced by SD remain unclear. We revealed that SD resulted in LXRβ reduction in the hippocampus, which was associated with upregulated expression of high mobility group box 1 (HMGB1)/toll-like receptor 4 (TLR4)/NF-κB p65, and knockdown of hippocampal LXRβ by shRNA (shLXRβ) led to cognitive impairment. GW3965, a dual agonist for both LXRα and LXRβ, ameliorated SD-induced cognitive impairment by inhibiting microglia activation, suppressing HMGB1/TLR4/NF-κB p65 pathway, and ultimately affecting the hippocampal expression of inflammatory cytokines in SD mice. LXRβ knockdown by shLXRβ abrogated the GW3965-mediated inhibition of the HMGB1/TLR4/NF-κB p65 pathway, therefore, abolishing the cognitive improvement. Moreover, inhibition of HMGB1 by glycyrrhizin (GLY) synergistic promoted GW3965-mediated anti-inflammation in activated microglia after lipopolysaccharide (LPS)/ATP stimulation and facilitated the cognitive improvement after GW administration by activating LXRβ. All the data suggested that GW3965 ameliorated impaired cognition in SD mice by suppressing the HMGB1/TLR4/NF-κB p65 pathway followed LXRβ activation. This study correlates a deficit of LXRβ in cognitive dysfunction in SD associated with HMGB1 inflammatory pathway in hippocampus, and LXRs may serve as a potential therapeutic target for cognitive impairment with anti-inflammation.

Keywords: Cognitive impairment; High mobility group box 1 (HMGB1); Liver X receptors; Microglia; Neuroinflammation; Sleep deprivation.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Benzoates / administration & dosage
  • Benzylamines / administration & dosage
  • Cognitive Dysfunction / drug therapy
  • Cognitive Dysfunction / metabolism*
  • Dose-Response Relationship, Drug
  • Glycyrrhizic Acid / administration & dosage
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Liver X Receptors / agonists
  • Liver X Receptors / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microinjections
  • Neuroinflammatory Diseases / drug therapy
  • Neuroinflammatory Diseases / metabolism*
  • Random Allocation
  • Sleep Deprivation / drug therapy
  • Sleep Deprivation / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Benzoates
  • Benzylamines
  • GW 3965
  • Liver X Receptors
  • Glycyrrhizic Acid